Dark

SCNI
Scinai Immunotherapeutics Ltd.
stock NASDAQ ADR

At Close

Jul 3, 2025 11:04:19 AM EDT

2.21USD-2.643%(-0.06)73,299

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 3, 2025 9:26:30 AM EDT

2.20USD-3.084%(-0.07)780

After-hours

Jul 3, 2025 4:38:30 PM EDT

2.24USD+1.357%(+0.03)1,860

OverviewHistoricalExchangesShortsTrends

open chart

Market Cap

2.18M

Headquarters

Po Box 4143 14 Einstein Street, Ness Ziona, Israel

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Last Split

May 21, 20241for10reverse

SCNI Stats

Avg. Vol. 10 Day

121,785

Avg. Vol. 30 Day

767,749

Market Cap

2,179,823

Shares Out.

999,919

On/Off Exchange

57%/43%

6 Month Beta

0.13

1 Year Beta

0.34

2 Year Beta

0.65

52 Week Low

1.90

52 Week High

8.92

SMA50

2.57

SMA200

3.14

1 Week

-4.39%

1 Month

-14.51%

3 Month

-18.05%

6 Month

-42.18%

1 Year

-28.99%

2 Year

-83.42%

Profile

biondvax (nasdaq: bvxv) is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. biondvax's technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.

SCNI Stock Summary

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) stock price today is $2.21, and today's volume is 73,299. SCNI is down -2.643% today. The 30 day average volume is 767,749. SCNI market cap is 2.18M with 999,919 shares outstanding.

.dark-mode .pZvvj1{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .pZvvj1{ color: #333333; background-color: white; border: 2px solid #333333; }SCNIScinai Immunotherapeutics Ltd.stock NASDAQ ADR

SCNI Stock Summary

SCNI
Scinai Immunotherapeutics Ltd.
stock NASDAQ ADR